Nader Khalidi Selected Research

Nader Khalidi Research Topics

Disease

7	Vasculitis (Vasculitides) 03/2024 - 01/2017
7	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2024 - 01/2017
6	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2022 - 12/2011
4	Asthma (Bronchial Asthma) 08/2023 - 01/2017
4	Giant Cell Arteritis (Horton Disease) 01/2023 - 01/2017
3	Eosinophilia 08/2023 - 01/2017
3	Infections 01/2022 - 01/2017
2	Microscopic Polyangiitis 01/2022 - 01/2020
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2019 - 01/2015
2	Headache (Headaches) 01/2019 - 01/2016
1	Majeed syndrome 08/2023
1	Familial Mediterranean Fever (Periodic Disease) 08/2023
1	Cryopyrin-Associated Periodic Syndromes 08/2023
1	Sarcoidosis (Schaumann Disease) 03/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Blood Vessel Dissection 12/2021
1	Systemic Scleroderma (Systemic Sclerosis) 10/2021
1	Fecal Incontinence 10/2021
1	Diabetes Mellitus 08/2020
1	Hemorrhage 01/2020
1	Diplopia (Double Vision) 01/2019
1	Jaw Abnormalities 01/2019
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Bacterial Endocarditis 01/2017
1	Glomerulonephritis 01/2017
1	Gangrene 12/2016
1	Calcinosis 12/2016
1	Necrosis 12/2016
1	digital ulcers 12/2016
1	Fatigue 01/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016
1	Nausea 01/2016
1	Rheumatoid Arthritis 04/2006

Drug/Important Bio-Agent (IBA)

6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2024 - 12/2011
4	GlucocorticoidsIBA 03/2024 - 01/2020
4	SteroidsIBA 01/2023 - 01/2017
3	Immunoglobulin G (IgG)IBA 08/2023 - 12/2011
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2020
2	AutoantibodiesIBA 12/2022 - 01/2017
2	CytokinesIBA 03/2022 - 01/2017
2	Monoclonal AntibodiesIBA 03/2022 - 01/2017
2	Immunoglobulin A (IgA)IBA 12/2021 - 12/2011
2	C-Reactive ProteinIBA 12/2021 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2017
2	Abatacept (Orencia)FDA Link 01/2017 - 01/2017
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2017 - 01/2017
1	InflammasomesIBA 08/2023
1	avacopanIBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	Infliximab (Remicade)FDA Link 03/2022
1	Myeloblastin (Proteinase 3)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	anticentromere antibodyIBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2020
1	Angiotensin Receptor AntagonistsIBA 08/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2020
1	PlasminogenIBA 01/2017
1	InterleukinsIBA 01/2017
1	Interleukin-5 (Interleukin 5)IBA 01/2017
1	AntigensIBA 01/2017
1	mepolizumabIBA 01/2017
1	RNA Polymerase IIIIBA 12/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2016
1	AntibodiesIBA 12/2016
1	pirfenidoneIBA 01/2016
1	Chemokine CCL26IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	HLA-DPB1 antigen (HLA DPB1)IBA 09/2013
1	Fc Receptors (Fc Receptor)IBA 12/2011
1	Etanercept (Enbrel)FDA Link 04/2006
1	Antirheumatic Agents (DMARD)IBA 04/2006

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2017
3	Plasma Exchange 03/2024 - 01/2020
2	Remission Induction 01/2023 - 01/2020
1	Surgical Amputation (Amputations) 12/2016